ArticleFrontiers in pharmacology2025

Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with adenine-induced chronic renal injury.

Lulu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.